Start for free
Start for free
JW

Jack W. Schuler Living Trust

Description

Jack W. Schuler Living Trust primarily operates as an investment firm.

Investor Profile

Jack W. Schuler Living Trust has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (67%)
  • Canada (33%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • 3d Printing
  • Manufacturing
  • Medical Device
  • Consulting
  • Health Diagnostics
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jack W. Schuler Living Trust frequently co-invest with?

SF
Schuler Family Foundation
North America, Illinois, United States, Lake Forest
Co-Investments: 1
Trellis Partners
Trellis Partners
North America, Texas, United States, Cedar Creek
Co-Investments: 1
Oracle Investment Management Inc.
Oracle Investment Management Inc.
North America, Connecticut, United States, Greenwich
Co-Investments: 1
Oracle
Oracle
North America, Texas, United States, Austin
Co-Investments: 2

Which angels does Jack W. Schuler Living Trust often collaborate with?

LN
Larry N. Feinberg
North America, Connecticut, United States, Greenwich
Shared Deals: 1

What are some of recent deals done by Jack W. Schuler Living Trust?

Biolase

Foothill Ranch, California, United States

Biolase develops lasers and related products for providing biological treatments that reduce pain.

3D PrintingBiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityNov 5, 2014
Amount Raised: $35,000,000
Transition Therapeutics

Toronto, Ontario, Canada

Transition Therapeutics is a biopharmaceutical company developing novel therapeutics for disease indications with large markets.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityJun 6, 2014
Amount Raised: $30,800,000
Accelerate Diagnostics

Tucson, Arizona, United States

Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections.

ConsultingHealth CareHealth DiagnosticsHospitalInformation Technology
Post Ipo EquityMay 5, 2014
Amount Raised: $45,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator